SCHEMBL9998152

SCHEMBL9998152

CC(=O)OCC=Cc1cccc2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD2 O60906 2/20 0.56
MTNR1A P48039 1/20 0.54
MTNR1B P49286 1/20 0.54
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
GRIK1 P39086 1/20 0.47
GRIK2 Q13002 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP1A1 P04798 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
NPY1R P25929 1/20 0.43
MAPK1 P28482 1/20 0.43
NPY2R P49146 1/20 0.43
CYP1B1 Q16678 1/20 0.43
NPC1 O15118 1/20 0.43
RXRA P19793 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998150 1.00 SMPD2 (0.56) SMPD2MTNR1AMTNR1BHDAC8HDAC6
SCHEMBL28708757 0.85 SMPD2 (0.56) SMPD2MTNR1AMTNR1BHDAC8HDAC6
SCHEMBL9998182 0.80 SMN1; SMN2 (0.43) SMN1; SMN2ALDH1A1CYP1A2CYP2D6MAPT
SCHEMBL1039973 0.80 MAPT (0.54) ALDH1A1MAPTMAPK1NPC1
SCHEMBL9998185 0.80 SMN1; SMN2 (0.43) SMN1; SMN2ALDH1A1CYP1A2CYP2D6MAPT
SCHEMBL28655523 0.79 RXRA (0.47) SMPD2MTNR1AMTNR1BHDAC8HDAC6
SCHEMBL9997449 0.78 MEN1 (0.46) HDAC8HDAC6GRIK1GRIK2SMN1; SMN2
SCHEMBL9997452 0.78 MEN1 (0.46) HDAC8HDAC6GRIK1GRIK2SMN1; SMN2
SCHEMBL9997271 0.78 HSD11B1 (0.50) ALDH1A1MAPTNPC1
SCHEMBL9998651 0.78 NFE2L2 (0.47) SMN1; SMN2ALDH1A1CYP1A2MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 SMPD2 3681/4885MTNR1A 2798/4885MTNR1B 2713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.